News

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26

Catheter-based treatment linked to major benefits for intermediate-risk PE

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.

FDA sees promise in voice-based AI model for heart failure

An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.

Breast cancer screening rates saw a 10% drop among several groups of women over the last 2 decades

Decreased screening rates among different subgroups highlight the ongoing need for outreach strategies that target vulnerable populations, experts contend.

Medtronic’s MiniMed 780G automated insulin delivery system

Software errors lead to major insulin pump recall—manufacturer shares a fix

Nearly 27,000 MiniMed 780G insulin pumps were included in a new Class II recall. By taking a few basic steps, however, patients should be able to avoid any significant risks.

William P. Shutze, MD, FACS, secretary of the Society of Vascular Surgery (SVS), a vascular surgeon with Texas Vascular Associates in Plano, Texas, and a clinical associate professor of medicine at Texas A&M College of Medicine, explained the role of vascular surgeons in peripheral artery disease (PAD) and critical limb ischemia (CLI).

Getting vascular surgeons more involved leads to key improvements for PAD patients

Vascular surgeons perform procedures interventional cardiologists and interventional radiologists do not do—so why not make sure they are part of every heart team conversation?

Northwestern deploys new mobile stroke unit equipped with 32-slice CT scanner

The MSU operates 365 days a year and covers 138 square miles. Hundreds of patients have been treated through the MSU, with more than 500 receiving critical care in it 2025 alone.

Activist investors sue UnitedHealth to force annual reporting on patient care access

Led by a Quebec-based faith organization, a coalition of investors is asking a court to force UnitedHealth to provide details on the social impacts of its history of mergers and acquisitions. The lawsuit comes after the plaintiffs, all company shareholders, failed to get the proposal passed through internal channels. The Securities and Exchange Commission has also opted not to intervene.

Medtronic enrolls first patient in new coronary DCB trial—data could lead to FDA approval

The paclitaxel-coated device, already approved in Europe and other parts of the world, will be tested on more than 1,200 patients for a new international trial. If the study is a success, Medtronic hopes to gain regulatory approval in the United States and Japan.

Radiology Partners fires back in battle with Aetna, accusing payer of ‘shamelessly prioritizing profits’

"We vehemently refute all their manufactured allegations, and we will vigorously defend our position," CEO Rich Whitney, MBA, said Wednesday.

Compremium has developed a noninvasive external assessment that does away with needles for the diagnosis of venous pressure conditions using AI-enabled monitoring.

Healthcare AI newsmakers: Chief AI & transformation officers, AI Rorschach testers, citizens united for responsible healthcare AI, more

Less alarm fatigue in overworked pediatric nurses means more time for imperiled pediatric patients.

Appeals court rejects radiologist’s attempt to revive whistleblower suit over ‘troubling’ IR colleague

Surgeons purportedly labeled the interventional rad the "Boston Butcher" after he allegedly flubbed several procedures, with 1 leading to a patient's death.

Around the web

Cardiovascular Business

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.